TrialsgrambetaRCTs are beautiful

BASIL-2

2023

Bypass versus Angioplasty for Severe Ischaemia of the Leg – 2

In 345 patients with chronic limb-threatening ischaemia requiring infra-popliteal revascularisation, a vein-bypass-first strategy worsened amputation-free survival compared with a best-endovascular-treatment-first strategy.

Result

Efficacy: Amputation-free survival (above-ankle amputation or death from any cause)adjusted HR 1.35 (95% CI 1.02-1.80) · P = 0.037

Below 1 favours a vein-bypass-first strategy, above 1 favours a best-endovascular-treatment-first strategy.

Event rates
Absolute difference
10 points
NNH
10

Absolute difference and NNH are derived from the event rates.

Also reported: Driven mainly by more deaths in the bypass arm (53 % vs 45 %).

Original publication
Subtopic
Revascularisation
Design
Open-label, pragmatic phase-3 RCT
Relevance
Important: one of several pillars.
Source
Bradbury AW, Moakes CA, et al. Lancet. 2023;401(10390):1798-1809.doi 10.1016/S0140-6736(23)00462-2

Discussion & critique

Small, open-label and driven by all-cause rather than limb-related death, so the mechanism of harm is unclear. Read against BEST-CLI it produces the guideline's nuanced position: anatomy and conduit, not dogma, should decide bypass versus endovascular therapy.